Stock ALT ALTIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Altimmune, Inc.

Equities

ALT

US02155H2004

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
7.56 USD +1.20% Intraday chart for Altimmune, Inc. +7.39% -32.80%
Apr. 02 Transcript : Altimmune, Inc. - Special Call
Mar. 27 Altimmune Shares Slip Wednesday, After Reporting a Wider Q4 Net Loss and Dropping Prospective Treatment for Hepatitis B MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Altimmune, Inc. - Special Call
Altimmune Shares Slip Wednesday, After Reporting a Wider Q4 Net Loss and Dropping Prospective Treatment for Hepatitis B
MT
Transcript : Altimmune, Inc., Q4 2023 Earnings Call, Mar 27, 2024
Altimmune, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Earnings Flash (ALT) ALTIMMUNE Reports Q4 Revenue $37,000
MT
Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
AQ
Altimmune, Inc. Announces Impairment Loss for the Three Months Ended December 31, 2023
CI
North American Morning Briefing : Stocks Edge -2-
DJ
Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024
AQ
North American Morning Briefing : Stock Futures -2-
DJ
Altimmune, Inc.(NasdaqGM:ALT) added to S&P Biotechnology Select Industry Index
CI
North American Morning Briefing : Inflation Data -2-
DJ
ROSEN, A LONGSTANDING LAW FIRM, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT
PR
Drugmakers deepen efforts to tap into booming market for obesity drugs
RE
Zealand shares surge on liver drug data from Boehringer pact
RE
Altimmune, Inc. (ALT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
BU
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT
PR
ROSEN, LEADING INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALT Stock
  4. News Altimmune, Inc.